Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs-Reference-Cited by-同舟云学术

Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs

Published:2012-01 Issue:1 Volume:21 Page:82-91
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Van der Veldt Astrid A.M.,Lubberink Mark,Bahce Idris,Walraven Maudy,de Boer Michiel P.,Greuter Henri N.J.M.,Hendrikse N. Harry,Eriksson Jonas,Windhorst Albert D.,Postmus Pieter E.,Verheul Henk M.,Serné Erik H.,Lammertsma Adriaan A.,Smit Egbert F.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference49 articles.

1. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients;Batchelor;Cancer Cell,2007

2. Evaluation of basis function and linear least squares methods for generating parametric blood flow images using 15O-water and Positron Emission Tomography;Boellaard;Mol. Imaging Biol.,2005

3. Mechanisms of angiogenesis and arteriogenesis;Carmeliet;Nat. Med.,2000

4. Adverse effects of anticancer agents that target the VEGF pathway;Chen;Nat. Rev. Clin. Oncol.,2009

5. A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer;Cobleigh;Semin. Oncol.,2003

Cited by 298 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyaluronidase improves the efficacy of nab-paclitaxel after prolonged angiogenesis inhibition in preclinical models for esophagogastric cancer;Biomedicine & Pharmacotherapy;2024-09

2. Targeting the tumour vasculature: from vessel destruction to promotion;Nature Reviews Cancer;2024-08-29

3. Characterizing microbubble-mediated permeabilization in a vessel-on-a-chip model;2024-08-28

4. Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?;Scientific Reports;2024-08-22

5. Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer;Oncogene;2024-08-02